468 results on '"Skowasch, Dirk"'
Search Results
2. Assessing sleep-related breathing disorders among newly diagnosed rheumatoid and psoriatic arthritis patients: a cross-sectional study
3. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry
4. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry
5. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
6. Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era
7. Dupilumab bei chronisch-obstruktiver Lungenerkrankung
8. Cardiac autonomic dysfunction in adult congenital heart disease
9. Relevance of serum levels of the endoplasmic reticulum stress protein GRP78 (glucose-regulated protein 78 kDa) as biomarker in pulmonary diseases
10. Prevalence of sleep-disordered breathing in patients with mitral regurgitation and the effect of mitral valve repair
11. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study
12. Real-World Data on Tezepelumab in Patients With Severe Asthma in Germany
13. ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling
14. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
15. Characterization of Obesity in Severe Asthma in the German Asthma Net
16. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
17. Systemic alterations in neutrophils and their precursors in early-stage chronic obstructive pulmonary disease
18. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
19. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE
20. Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis
21. Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis
22. Aktuelle Entwicklungen in der Schlafforschung und Schlafmedizin – eine Einschätzung der AG „Herz- und Kreislauferkrankungen“
23. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
24. YoungDGP-Pilotprojekt Pneumo Speed Dating – Innovatives Fortbildungsformat mit Zukunftspotenzial.
25. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
26. Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
27. No evidence to support the impact of migration background on treatment response rates and cancer survival: a retrospective matched-pair analysis in Germany
28. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
29. Discovering single cannabidiol or synergistic antitumor effects of cannabidiol and cytokine-induced killer cells on non-small cell lung cancer cells.
30. Therapie der Sarkoidose. Ein Positionspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP).
31. Allergische bronchopulmonale Aspergillose (ABPA) – ein Update.
32. Sarkoidose – Mechanismen und Bildgebung.
33. Impact of interstitial lung disease on left ventricular myocardial function.
34. Phenotypes and treatment outcomes in idiopathic pulmonary arterial hypertension patients with comorbidities.
35. COPD-Exazerbation frühzeitig erkennen und behandeln
36. Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome
37. Anxiety and depression in patients three months after myocardial infarction: Association with markers of coagulation and the relevance of age
38. A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer Center
39. Diagnostik und Therapie der pulmonalarteriellen Hypertonie.
40. Pulmonale Hypertonie assoziiert mit Lungenerkrankungen.
41. Medikamentöse Therapie der pulmonalarteriellen Hypertonie mit Komorbiditäten – Welche Phänotypen gibt es, was gibt es zu beachten?
42. Lung cancer screening with MRI: results of the first screening round
43. Obstructive sleep apnea and cardiovascular disease: a cause apparent but not yet evident
44. The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registry
45. Health Care Situation in the Treatment of Uncontrolled GINA Step 4/5 Patients in Germany.
46. Preclinical atherosclerotic burden in carotid and lower extremity arteries in adults with congenital heart disease.
47. Mehr Klarheit für PAH-Therapie bei Vorliegen von Komorbiditäten
48. Kommentar zu „Benralizumab reduziert Kortikosteroid-Bedarf".
49. Long-term effects of ACE inhibitor on vascular remodelling
50. Impact of short-term pausing of oral corticosteroids on blood eosinophil count in patients with severe asthma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.